colistimethate sodium has been researched along with Pneumonia, Ventilator-Associated in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benítez-Cano, A; Bermejo, S; Campillo, N; Carazo, J; de Antonio-Cuscó, M; Grau, S; Horcajada, JP; Luque, S; Ramos, I; Samsó, E; Sorlí, L | 1 |
| Boisson, M; Cormier, M; Couet, W; Gobin, P; Grégoire, N; Marchand, S; Mimoz, O | 1 |
| Arbelot, C; Becquemin, MH; Bertholon, JF; Bihan, K; Langeron, O; Lu, Q; Lu, X; Monsel, A; Rouby, JJ; Vezinet, C; Zahr, N | 1 |
| Boisson, M; Couet, W; Gobin, P; Grégoire, N; Jacobs, M; Marchand, S; Mimoz, O | 1 |
| Angkasekwinai, N; Lorsutthitham, J; Rattanaumpawan, P; Thamlikitkul, V; Ungprasert, P | 1 |
| Baltopoulo, G; Boutzouka, E; Fousteri, M; Markantonis, SL; Markou, N; Tsigou, E | 1 |
| Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS | 1 |
1 trial(s) available for colistimethate sodium and Pneumonia, Ventilator-Associated
| Article | Year |
|---|---|
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome | 2010 |
6 other study(ies) available for colistimethate sodium and Pneumonia, Ventilator-Associated
| Article | Year |
|---|---|
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prospective Studies | 2019 |
Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colistin; Critical Illness; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated | 2017 |
Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Anti-Bacterial Agents; Colistin; Cross-Over Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated; Prospective Studies; Young Adult | 2018 |
Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
Topics: Administration, Inhalation; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biotransformation; Colistin; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Extracellular Fluid; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Half-Life; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pneumonia, Ventilator-Associated | 2014 |
Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium.
Topics: Bronchoalveolar Lavage Fluid; Colistin; Critical Illness; Humans; Injections, Intravenous; Pneumonia, Ventilator-Associated | 2011 |
Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Anti-Bacterial Agents; Colistin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome | 2012 |